EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Equillium, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.24+0.05 (+4.20%)
Close on Oct 19, 2026
- Market cap
- $138.64M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Equillium has not reported a dividend
No dividend per share appears in Equillium's annual filings since fiscal 2017.